Increased baseline occupancy of D2 receptors by dopamine in schizophrenia - Wikidata - thesis-toulmin - TriplyDB

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

http://www.wikidata.org/entity/Q24676113

about

Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?The dopamine hypothesis of schizophrenia: version III--the final common pathway Fluphenazine (oral) versus placebo for schizophrenia Fluphenazine (oral) versus placebo for schizophrenia Schizophrenia: more dopamine, more D2 receptors Neurotensin-deficient mice show altered responses to antipsychotic drugs Motor coordination deficits in mice lacking RGS9 Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.Animal models of schizophrenia: a critical review Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia The impact of leptin on perinatal development and psychopathology The dopaminergic system in autoimmune diseases Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia Social behavior in a genetic model of dopamine dysfunction at different neurodevelopmental time points.Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity Differential repression by freud-1/CC2D1A at a polymorphic site in the dopamine-D2 receptor gene Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia.Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice Model-based parametric study of frontostriatal abnormalities in schizophrenia patients Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.Maternal Immune Activation Disrupts Dopamine System in the Offspring Molecular substrates of schizophrenia: homeostatic signaling to connectivity Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study Drosophila Dopamine2-like receptors function as autoreceptors A receptor-based model for dopamine-induced fMRI signal.GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes.How antipsychotics work-from receptors to reality.Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy Reward processing in autism: a thematic series.Prenatal stress: role in psychotic and depressive diseases.Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats Dopaminergic dysfunction in schizophrenia: salience attribution revisited.

P2860

Q21203814-AA7335CD-98B6-4D62-9FF8-A35EBB426F93 Q21260315-E7E99AAC-9118-4691-A827-FD87AD4F85B1 Q22242827-65D7F1EC-121D-4810-85BF-F96A65D3D587 Q24201157-A3409CC5-D0EE-440B-B6D9-08B4066AE0F4 Q24243129-23BD86C7-C79E-40F7-AB36-19897F1FC7E9 Q24630726-410F7D64-87A5-4FDE-8C6C-FFE2CFDAC594 Q24632801-328EB553-78F4-4DA4-8811-168C488D9C32 Q24648527-93BD03AB-68E0-42D8-9FF2-5FC8F7BDBF92 Q24657796-BE26A09B-ECD6-41DB-82CB-A704199F7697 Q24674909-7E2DB3AC-16FE-4D8B-B758-F00EF1E6C01D Q24678573-56FDCA3B-3D44-4287-A2CA-27D1FDC5F40B Q26773403-006E428A-6B02-4052-A993-93B1878E9A22 Q26865196-1E3E0855-AF51-4BC8-B099-072BD241CB8F Q27023885-9B5E797E-DEAE-4EA8-91D6-A35D3C0E83F6 Q27026382-64CAA63A-C2D9-4866-B39A-286EF8EAD59B Q27349627-42FA361E-61F6-48E1-BAB2-F54664A7EADD Q28257109-F6B4AF74-2DAA-4AC6-9B6A-BDC80D55E230 Q28281024-1E3EB8CD-2C36-4357-9AC2-5C135059F2EC Q28304267-7388503E-1471-4296-ACA3-1F79A8DC6798 Q28361356-EF82E9DB-1D58-46B3-B256-712FB7DC1FD2 Q28474235-D2F60E05-79E3-4D41-8237-AE22EC10FEC8 Q28484377-5551907B-E124-44CB-AF69-2594CA941789 Q28587873-97B76B6A-0F72-4FE7-AFF5-DA3AB532FC30 Q28748228-D4BD0DAA-6A71-437A-966B-7D205E70D7F5 Q28749574-7D36DE0F-B45A-4023-91AC-185D21FC4EBB Q28754716-EAE6714F-0369-4CCE-B26E-49C7D7621716 Q30368373-CCEF2EE2-7D1F-4BBD-80AB-EAA52836D45A Q30375583-394F5474-76D8-4DCD-84EC-B9364A8C9652 Q30377656-A4E3584E-5BDD-42FE-A197-360AF9712E42 Q30383611-1BF92FF7-0F85-40C5-835F-58D74F8D4D58 Q30410514-2DBFA6A8-9135-4085-B4E3-1BF02A1D4571 Q30423268-CBC584B5-3FEB-4098-8988-5F2B68D06FE2 Q30434854-85EC5CA8-9CB3-40DE-AB9D-4063309003C4 Q30451228-BDF8336C-6402-436A-AC99-E4ADE4AB97CD Q30457477-3BD808FD-98EF-43A3-A538-801010FB2DD7 Q30457808-D0A1FBF1-532B-42D8-BC16-5F0B900AE670 Q30462673-3F2F21A9-92BB-48BD-AC67-D60BA85C4732 Q30470115-ECC75EBF-39A4-4494-AC99-05385A4C64AA Q30475004-6449F0C3-1755-4B93-AA1A-FC7F250D3E72 Q30475711-6E199625-766A-41BF-8632-13E29F379F91

P2860

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

http://www.wikidata.org/entity/Q24676113

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@ast

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@en

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@nl

type

label

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@ast

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@en

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@nl

prefLabel

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@ast

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@en

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@nl

P1433

Q24676113-20FDD504-2EC4-411A-A680-6BBFFF6B9FBE

P1476

Q24676113-8990AE22-E89B-4C96-99B2-E5D9DB885347

P2093

Q24676113-0CC199DF-2277-4187-B6C7-ED20953756F8

Q24676113-17287342-C8BF-416A-9A79-4C395E2D9670

Q24676113-1ACC5871-2531-4703-80D4-B06687FE9B78

Q24676113-26DBD28C-E28B-44F4-B24E-11F9DA712B58

Q24676113-41353F5F-3EE2-4143-B45D-8FACA50CD6BD

Q24676113-4B7FDA65-3EEC-4185-8D99-0CD8281BEFBC

Q24676113-5402EA77-6C69-4459-89DD-D49EA49C1756

Q24676113-80EA1943-C95C-4521-9CC8-E3B7CE4C1756

Q24676113-A3F94EB0-719F-46DB-9FA1-19361D5FC41B

Q24676113-B221D022-FFF6-4A08-9E2D-AD89F5DCD29D

P2860

Q24676113-10EE4DE3-0671-42CD-AECD-9C4F5BF90875

Q24676113-192AF155-2382-4064-9FF9-2FA3837FC2C5

Q24676113-1A30C63B-6889-4D25-96CF-638491E8181B

Q24676113-21F6E52A-00E9-409F-AD02-3EB772ACB22A

Q24676113-247C9132-40B1-4E21-B406-565F39542DED

Q24676113-25289A26-6941-4B11-9E6D-C295AC560EF3

Q24676113-29F22579-E344-4E3F-AC7D-B9AEA006802A

Q24676113-2E938259-FA5B-46BD-B649-90382BB74950

Q24676113-36C270C7-D3A4-4A82-8DB8-5C44E65FD54C

Q24676113-38DD9321-9080-44D0-A81B-D501DE8C4889

P304

Q24676113-F3452625-C820-4F51-AEE2-03B0AF4A052A

P31

Q24676113-2BB4AD37-E0E2-4E3D-B884-2496B9D2948B

P3181

Q24676113-54C5345D-D7EC-4C99-A7C9-50D61ADE728D

P356

Q24676113-586BF5E4-A4D6-4AAC-B1CC-C4DE50F81759

P407

Q24676113-034743E9-D3C2-49AB-A207-4E87B335F19D

P433

Q24676113-AAAE8145-D99D-4B59-BAB4-771CFB24EFF2

P478

Q24676113-AF015515-885D-4089-977B-BDC7273DDE71

P577

Q24676113-ECEBB201-5E6A-49A0-AAD6-83B33A991092

P5875

Q24676113-EC4587EA-A172-458F-90C0-E1CC35FEC99E

P698

Q24676113-DAD5DCDA-A4EF-414D-96A5-4CD03F69AFE6

P921

Q24676113-7c40eb17-69ad-435f-bc6e-d46c8d6c20e0

Q24676113-97E57514-C931-4B3B-B1E9-7AFFD30B708B

P932

Q24676113-E4184221-53DB-4A59-A0C4-831F7137641C

P3181

P356

PNAS.97.14.8104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

@en

P2093

A Abi-Dargham

http://www.w3.org/2001/XMLSchema#string

D Printz

http://www.w3.org/2001/XMLSchema#string

J J Mann

http://www.w3.org/2001/XMLSchema#string

J M Gorman

http://www.w3.org/2001/XMLSchema#string

J Rodenhiser

http://www.w3.org/2001/XMLSchema#string

L S Kegeles

http://www.w3.org/2001/XMLSchema#string

M Laruelle

http://www.w3.org/2001/XMLSchema#string

R Gil

http://www.w3.org/2001/XMLSchema#string

R L Van Heertum

http://www.w3.org/2001/XMLSchema#string

R Weiss

http://www.w3.org/2001/XMLSchema#string

P2860

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

The positive and negative syndrome scale (PANSS) for schizophrenia

Implications of normal brain development for the pathogenesis of schizophrenia

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Epidemiology and natural history of schizophrenia.

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.

P304

8104-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2447025

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.97.14.8104

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

238830224

http://www.w3.org/2001/XMLSchema#string

P698

10884434

http://www.w3.org/2001/XMLSchema#string

P921

P932

16677

http://www.w3.org/2001/XMLSchema#string